Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the mu receptor.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Life Science

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0024-3205(94)90038-8PMID 8196473
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular cloning and functional expression of a mu opioid receptor from rat brain

  1994cited by this paper
• Pharmacological mechanisms of opioid analgesics.

  1993cited by this paper
• Mushroom bodies and Drosophila learning.

  1993cited by this paper
• Molecular cloning and functional expression of a mu-opioid receptor from rat brain.

  1993cited by this paper
• Cloning and pharmacological characterization of a rat mu opioid receptor.

  1993cited by this paper
• Synergistic brainstem interactions for morphine analgesia.

  1993cited by this paper
• Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides.

  1993cited by this paper
• Cloning and expression of a cDNA for the rat kappa-opioid receptor.

  1993cited by this paper
• Cloning and expression of a cDNA for the rat k‐opioid receptor

  1993cited by this paper
• Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions

  1993cited by this paper
• A specific antisense oligodeoxynucleotide to mRNAs encoding receptors with seven transmembrane spanning regions decreases muscarinic m2 and gamma-aminobutyric acidB receptors in rat cerebellar granule cells.

  1993cited by this paper
• Cloning of a delta opioid receptor by functional expression.

  1992cited by this paper
• Anti-sense oligodeoxynucleotides--promises and pitfalls.

  1992cited by this paper
• Anti-sense oligodeoxynucleotides--promises and pitfalls.

  1992cited by this paper
• Antisense RNA and DNA.

  1990cited by this paper
• Blockade of morphine analgesia by both pertussis and cholera toxins in the periaqueductal gray and locus coeruleus.

  1990cited by this paper
• Role of mu 1-opiate receptors in supraspinal opiate analgesia: a microinjection study.

  1988cited by this paper

• Application of Antisense Conjugates for the Treatment of Myotonic Dystrophy Type 1

  2023cites this paper
• Sex differences in acute delta-9-tetrahydrocannabinol (Δ9-THC) response and tolerance as a function of mouse strain

  2023cites this paper
• Direct Administration and Gene Modulation Using Antisense Oligonucleotides Within the CNS

  2020cites this paper
• Interactive Mechanisms of Supraspinal Sites of Opioid Analgesic Action: A Festschrift to Dr. Gavril W. Pasternak

  2020cites this paper
• Gene Profiles in the Early Stage of Neuronal Differentiation of Mouse Bone Marrow Stromal Cells Induced by Basic Fibroblast Growth Factor

  2020cites this paper
• Emerging Insights into Mu Opioid Pharmacology.

  2019cites this paper
• Supraspinal and Peripheral, but Not Intrathecal, σ1R Blockade by S1RA Enhances Morphine Antinociception

  2019cites this paper
• Mu Opioid Pharmacology: 40 Years to the Promised Land.

  2018cites this paper
• Genetic dissociation of morphine analgesia from hyperalgesia in mice

  2017cites this paper
• Tetrapeptide Endomorphin Analogs Require Both Full Length and Truncated Splice Variants of the Mu Opioid Receptor Gene Oprm1 for Analgesia.

  2016cites this paper
• Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2.

  2016cites this paper
• Delta opioid agonists: a concise update on potential therapeutic applications

  2015cites this paper
• Splice variation of the mu-opioid receptor and its effect on the action of opioids

  2014cites this paper
• Mu Opioids and Their Receptors: Evolution of a Concept

  2013cites this paper
• Alternative Pre‐mRNA Splicing of Mu Opioid Receptor Gene

  2013cites this paper
• Stabilization of the μ-Opioid Receptor by Truncated Single Transmembrane Splice Variants through a Chaperone-like Action*

  2013cites this paper
• The role of multidrug resistance‐associated protein in the blood–brain barrier and opioid analgesia

  2013cites this paper
• Variants through a Chaperone-like Action Truncated Single Transmembrane Splice-Opioid Receptor by μ Stabilization of the Molecular Bases of Disease :

  2013cites this paper
• Heterogeneity of mu-opioid receptors as one of the factors sensitive to narcotic analgesics

  2013cites this paper
• Preclinical pharmacology and opioid combinations.

  2012cites this paper
• Alternative Pre-mRNA Splicing of G Protein-Coupled Receptors

  2011cites this paper
• Identification and characterization of seven new exon 11-associated splice variants of the rat mu opioid receptor gene, OPRM1

  2011cites this paper
• Molecular Biology of Mu Opioid Receptors

  2011cites this paper
• Mu opioid receptors in pain management.

  2011cites this paper
• Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions

  2009cites this paper
• Modulation of Brainstem Opiate Analgesia in the Rat by σ1 Receptors: A Microinjection Study

  2007cites this paper
• Modulation of brainstem opiate analgesia in the rat by sigma 1 receptors: a microinjection study.

  2007cites this paper
• Organ-specific approaches: Pain management

  2006cites this paper
• An antisense oligodeoxynucleotide to the mu opioid receptor attenuates cocaine-induced behavioral sensitization and reward in mice.

  2006cites this paper
• Proceedings of the Symposium "Updates of the Clinical Pharmacology of Opioids with Special Attention to Long-Acting Drugs"

  2005cites this paper
• Diversity and Complexity of the Mu Opioid Receptor Gene: Alternative Pre-mRNA Splicing and Promoters

  2005cites this paper
• Identification and characterization of six new alternatively spliced variants of the human μ opioid receptor gene, Oprm

  2005cites this paper
• Molecular biology of opioid analgesia.

  2005cites this paper
• Morphine more fine? Its effects in critically ill newborns

  2004cites this paper
• Multiple opiate receptors: déjà vu all over again.

  2004cites this paper
• Functional analysis of MOR‐1 splice variants of the mouse mu opioid receptor gene Oprm

  2004cites this paper
• Multiple KH Domains of Poly C Binding Protein are Required for its Trans-Activation on the Proximal Promoter of the Mu-Opioid Receptor Gene

  2004cites this paper
• Identification of three new alternatively spliced variants of the rat mu opioid receptor gene: dissociation of affinity and efficacy

  2004cites this paper
• The Opioid Receptors

  2003cites this paper
• Ten years of antisense inhibition of brain G-protein-coupled receptor function.

  2003cites this paper
• Chapter I Opioid receptors

  2002cites this paper
• Pharmacological characterization of the dermorphin analog [Dmt(1)]DALDA, a highly potent and selective mu-opioid peptide.

  2001cites this paper
• Incomplete cross tolerance and multiple mu opioid peptide receptors.

  2001cites this paper
• Book Review: The Pharmacology of Mu Analgesics: From Patients to Genes

  2001cites this paper
• Morphine-6beta-glucuronide and morphine-3-glucuronide, opioid receptor agonists with different potencies.

  2001cites this paper
• Intraperitoneal injection of antisense peptide nucleic acids targeted to the mu receptor decreases response to morphine and receptor protein levels in rat brain.

  2001cites this paper
• Expression of antinociception in response to a signal for shock is blocked after selective downregulation of mu-opioid receptors in the rostral ventromedial medulla.

  2000cites this paper
• Antisense mapping: assessing functional significance of genes and splice variants.

  2000cites this paper
• Differential distribution in rat brain of mu opioid receptor carboxy terminal splice variants MOR‐1C‐like and MOR‐1‐like immunoreactivity: Evidence for region‐specific processing

  2000cites this paper
• Identifying pain genes: bottom-up and top-down approaches.

  2000cites this paper
• Comparative immunohistochemical distributions of carboxy terminus epitopes from the mu-opioid receptor splice variants MOR-1D, MOR-1 and MOR-1C in the mouse and rat CNS.

  2000cites this paper
• Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR‐1F

  2000cites this paper
• Time course of changes in mu-opioid receptor mRNA levels in the periaqueductal gray of rat brain by a single or repeated injections of antisense oligodeoxynucleotides.

  1999cites this paper
• Mmu and D2 receptor antisense oligonucleotides injected in nucleus accumbens suppress high alcohol intake in genetic drinking HEP rats.

  1999cites this paper
• The δ-Opioid Receptor: Molecular Pharmacology, Signal Transduction, and the Determination of Drug Efficacy

  1999cites this paper
• Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms.

  1999cites this paper
• Effects of antisense oligonucleotides on brain delta‐opioid receptor density and on SNC80‐induced locomotor stimulation and colonic transit inhibition in rats

  1999cites this paper
• Antibodies and antisense oligodeoxynucleotides to μ‐opioid receptors, selectively block the effects of μ‐opioid agonists on intestinal transit and permeability in mice

  1999cites this paper
• Antisense RNA gene therapy for studying and modulating biological processes

  1999cites this paper
• Antisenses to opioid receptors attenuate ATP-gated K(+) channel opener-induced antinociception.

  1999cites this paper
• Mμ and D2 Receptor Antisense Oligonucleotides Injected in Nucleus Accumbens Suppress High Alcohol Intake in Genetic Drinking HEP Rats

  1999cites this paper
• Phosphorothioate oligodeoxynucleotides can selectively alter neuronal activity in the cochlea.

  1999cites this paper
• Antisense Oligodeoxynucleotides Targeting Distinct Exons of the Cloned mu-Opioid Receptor Distinguish Between Endomorphin-1 and Morphine Supraspinal Antinociception in Mice

  1999cites this paper
• Retention of heroin and morphine–6β–glucuronide analgesia in a new line of mice lacking exon 1 of MOR–1

  1999cites this paper
• Morphine-6β-Glucuronide-Induced Hyperphagia: Characterization of Opioid Action By Selective Antagonists and Antisense Mapping in Rats

  1998cites this paper
• Antisense Oligodeoxynucleotides as Specific Tools for Studying Opioid Receptor-Mediated Analgesia

  1998cites this paper
• Antisense Oligodeoxynucleotides to the Kappa1 Receptor Enhance Δ9-THC–Induced Antinociceptive Tolerance

  1998cites this paper
• Evidence for additional neurotensin receptor subtypes: neurotensin analogs that distinguish between neurotensin-mediated hypothermia and antinociception.

  1998cites this paper
• Time course of morphine withdrawal and preproenkephalin gene expression in the periaqueductal gray of rats.

  1998cites this paper
• Specific gene blockade shows that peptide nucleic acids readily enter neuronal cells in vivo

  1998cites this paper
• Antisense Mapping of MOR-1 in Rats : Distinguishing between Morphine and Morphine-6 b-glucuronide Antinociception 1

  1997influential citation
• Antisense strategies in neurobiology.

  1997cites this paper
• Neuroendocrine and behavioral effects of antisense oligonucleotides.

  1997cites this paper
• Reduced expression of alpha2C-adrenoceptors in rat striatum following antisense oligodeoxynucleotide infusion.

  1997cites this paper
• Critical issues in the antisense inhibition of brain gene expression in vivo: experiences targetting the 5-HT1A receptor.

  1997cites this paper
• Infusions of Tyrosine Hydroxylase Antisense Oligodeoxynucleotide into Substantia Nigra of the Rat: Effects on Tyrosine Hydroxylase mRNA and Protein Content, Striatal Dopamine Release and Behaviour

  1997cites this paper
• Antisense mapping of the MOR-1 opioid receptor clone: modulation of hyperphagia induced by DAMGO.

  1997cites this paper
• 3H-Morphine-6β-Glucuronide Binding in Brain Membranes and an MOR-1-Transfected Cell Line

  1997cites this paper
• Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like K+ channel.

  1997cites this paper
• Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse

  1997cites this paper
• Cholecystokinin antisense RNA increases the analgesic effect induced by electroacupuncture or low dose morphine: conversion of low responder rats into high responders

  1997cites this paper
• Antisense oligodeoxynucleotides to opioid mu and delta receptors reduced morphine dependence in mice: role of delta-2 opioid receptors.

  1997cites this paper
• Effect of supraspinal antisense oligodeoxynucleotide treatment on delta-opioid receptor mRNA levels in mice.

  1997cites this paper
• The effect of mu-opioid receptor antisense on morphine potency and antagonist-induced supersensitivity and receptor upregulation.

  1997cites this paper
• Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6beta-glucuronide antinociception.

  1997cites this paper
• Antisense mapping DOR-1 in mice: further support for delta receptor subtypes.

  1997cites this paper
• Multiple Receptors Involved in Peripheral α2, μ, and A1 Antinociception, Tolerance, and Withdrawal

  1997cites this paper
• 3 H-Morphine-6 b-Glucuronide Binding in Brain Membranes and an MOR-1-Transfected Cell Line 1

  1997cites this paper
• 3‐Methoxynaltrexone, a selective heroin/morphine‐6β‐glucuronide antagonist

  1997cites this paper
• Antisense mapping DOR-1 in mice: further support for δ receptor subtypes

  1997cites this paper
• Use of antisense oligodeoxynucleotide to determine delta-opioid receptor involvement in [D-Ala2]deltorphin II-induced locomotor hyperactivity.

  1996cites this paper
• Selective attenuation of mu-opioid receptor-mediated effects in rat sensory neurons by intrathecal administration of antisense oligodeoxynucleotides.

  1996cites this paper
• Molecular therapy for renal diseases.

  1996cites this paper
• Antisense confirmation of mu- and kappa-opioid receptor mediation of morphine's effects on body temperature in rats.

  1996cites this paper
• The genetics of pain and pain inhibition.

  1996cites this paper
• Opioids and the Control of Pain

  1996cites this paper
• Antibodies directed against the mu-opioid receptor alleviated multiple signs of morphine withdrawal in mice.

  1996cites this paper
• Antisense oligodeoxynucleotides against the MOR-1 clone alter weight and ingestive responses in rats.

  1996cites this paper
• Biological System Dynamics: From Personal Discovery to Universal Application

  1996cites this paper
• Antisense technology reveals the alpha2A adrenoceptor to be the subtype mediating the hypnotic response to the highly selective agonist, dexmedetomidine, in the locus coeruleus of the rat.

  1996cites this paper